| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_815d0960a725f73301d6ef292a353ec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a0d01edb66a2afbad745ea458375b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d7c19795ff0c7c7bea0d6edc8fdc550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_367e2cd549cf6638739c273a9aa5bc03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_163c070362bedec524f8febc5d80b260 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-912 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf2a283c889e61d83bdbfcef4216e58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f0a1f94c6a3d4fafae6ad8d9f276e96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b77bdf8b8d6f88b569ad518bce85ca5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd490a23bbafc373abef4a1ebccfeba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d4ffd6c57717af9384d621cd985bce |
| publicationDate |
2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009141926-A1 |
| titleOfInvention |
Method for acquisition of compound capable of acting on glucose metabolism/lipid metabolism |
| abstract |
Disclosed is a method for the screening of a substance which can modulate the interaction between at least two components selected from PHF2, ARID5B, FXR and a complex thereof or a substance which can modulate the gene expression through FXR or a glucagon signaling system. The method for the screening of the above-mentioned modulation substance comprises the steps of: contacting at least two proteins selected from the group consisting of PHF2, ARID5B and FXR with each other in the presence of any one of substances to be tested; detecting the formation of a complex of the proteins; and selecting a substance which modulates the interaction between the proteins or a substance which modulates the gene expression or the glucagon signaling system from the substances based on the results of the detection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019528457-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109628611-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109628611-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7038707-B2 |
| priorityDate |
2008-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |